Kumagi et al evaluated patients with primary biliary cirrhosis (PBC) and identified factors predictive of long-term histologic progression. A patient at risk for progression may benefit from more aggressive management or a novel therapy.The authors are from Toronto Western Hospital, the University Health Network and the University of Toronto.